BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UW Department of Psychiatry - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UW Department of Psychiatry
X-ORIGINAL-URL:https://www.psychiatry.wisc.edu
X-WR-CALDESC:Events for UW Department of Psychiatry
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20170312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20171105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191121T000000
DTEND;TZID=America/Chicago:20191121T000000
DTSTAMP:20260404T042834
CREATED:20191121T200446Z
LAST-MODIFIED:20191121T200507Z
UID:4184-1574294400-1574294400@www.psychiatry.wisc.edu
SUMMARY:Women’s Health Case Conference - Zachary Stowe\, MD
DESCRIPTION:Women’s Mental Health covers a wide range of situations (e.g. psychiatric illness\, trauma\, body image\, peripartum/reproductive health/loss\, pelvic pain\, etc.).
URL:https://www.psychiatry.wisc.edu/event/womens-health-case-conference-zachary-stowe-md/
CATEGORIES:CME,Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191115T120000
DTEND;TZID=America/Chicago:20191115T131500
DTSTAMP:20260404T042834
CREATED:20190215T214815Z
LAST-MODIFIED:20191009T190329Z
UID:3517-1573819200-1573823700@www.psychiatry.wisc.edu
SUMMARY:Karen J. Parker\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Advances in Detecting and Treating Autism\nKaren J. Parker\, PhD\nAssociate Professor\nDirector\, Social Neurosciences Research Program\nDepartment of Psychiatry and Behavioral Sciences\nStanford University School of Medicine \nReading List: \n\nCerebrospinal Fluid Vasopressin and Symptom Severity in Children with Autism\nA randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism\nArginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates\nEarly Predictors of Impaired Social Functioning in Male Rhesus Macaques\n\n\nDr. Parker is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University where she directs the Social Neurosciences Research Program. Dr. Parker’s research expertise is the biology of social functioning\, with a particular interest in oxytocin and vasopressin signaling pathways. Her preclinical research program focuses on developing novel animal models of social impairments; her clinical research program encompasses biomarker discovery and therapeutic testing in patients with autism and other brain disorders. \nDr. Parker received her undergraduate and graduate degrees from the University of Michigan and completed postdoctoral training at Stanford University. Dr. Parker joined the Stanford faculty in 2007. She is an Affiliate Scientist at the California National Primate Research Center\, a Member of the American College of Neuropsychopharmacology\, and a Kavli Fellow of the US National Academy of Sciences. Dr. Parker’s research program has been supported by multiple funding agencies including the NIH\, Simons Foundation\, and NARSAD. Dr. Parker serves on the Editorial Board of Psychoneuroendocrinology\, and on various national (e.g.\, NIH and NSF) and international (e.g.\, Medical Research Council) grant review committees and scientific panels. \nDr. Parker was born in Boulder\, CO and grew up in suburban Chicago\, IL. She lives in the San Francisco Bay Area with her husband (a high-tech executive)\, three children\, and an Australian shepherd. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/karen-j-parker-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191016T120000
DTEND;TZID=America/Chicago:20191016T130000
DTSTAMP:20260404T042834
CREATED:20190215T231416Z
LAST-MODIFIED:20191008T202258Z
UID:3544-1571227200-1571230800@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Laura Buyan Dent\, MD - "An Update on Tardive Dyskinesia"
DESCRIPTION:An Update on Tardive Dyskinesia \nLaura Buyan Dent\, MD \nLearning Objectives: \n\nIdentify various forms of tardive dyskinesia\nDescribe rationale to prevent development of tardive dyskinesia\nIdentify treatment options\, including recently available medications\n\nLocation:\n4th Floor Conference Room\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\nAbout the Speaker:\n\nDr. Laura Buyan Dent is a neurologist in the Movement Disorders Program. Dr. Buyan Dent’s main focus is the care of patients with Parkinson’s disease\, Huntington’s disease\, essential tremor\, dystonia\, multiple systems atrophy\, progressive supranuclear palsy and other movement disorders. With state-of-the-art pharmaceutical treatments\, botulinum toxin injections and surgical management options\, Dr. Buyan Dent helps patients with a unique program that suits their particular conditions. \nAs part of the Performing Arts Medicine Program\, she is dedicated to the care of artists with neurologic conditions such as tremors\, dystonias and ataxias\, that may interfere with performance and movement. She also helps with performance-related overuse conditions or injuries that result in focal dystonia\, nerve injuries\, weakness\, tremors and coordination difficulties. \nhttps://www.uwhealth.org/findadoctor/profile/laura-j-buyan-dent-md-phd/5637 \n\nAbout the Series: \nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-laura-buyan-dent-md-topic-tardive-dyskinesia/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191011T073000
DTEND;TZID=America/Chicago:20191012T120000
DTSTAMP:20260404T042834
CREATED:20190930T214417Z
LAST-MODIFIED:20190930T214417Z
UID:4065-1570779000-1570881600@www.psychiatry.wisc.edu
SUMMARY:7th Annual Update and Advances in Psychiatry Conference
DESCRIPTION:REGISTER VIA ICEP PORTAL:\nhttps://ce.icep.wisc.edu/2019-Annual-Update#group-tabs-node-course-default6 \n\nAvailable credit:\n\n\n\n\n9.00 AMA PRA Category 1 Credit™\n9.00 University of Wisconsin–Madison Continuing Education Hours\n\n\n\n\nSTATEMENT OF NEED\nThis activity is being held in response to mental health professionals’ previous conference evaluations and the need for ongoing continuing medical education for clinicians in the area of psychiatry. \nELEMENTS OF COMPETENCE\nThis CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties’ areas of medical knowledge and patient care and procedural skills. \n\n\n\n\nTARGET AUDIENCE\n\n\n\nThis educational activity has been designed to meet the needs of clinicians and other health care professionals who are looking to enhance their knowledge and skills for the care of their patients with mental health issues. \n\n\n\n\n\nLEARNING OBJECTIVES\n\n\n\nAt the conclusion of this educational activity\, participants should be able to: \n\nDescribe the data supporting efficacy and risks associated with transcranial magnetic stimulation in the treatment of major depressive disorder\nDevelop a plan to address substances use disorders in their patients who are children or adolescents\nManage the challenges associated with caring for patients with personality disorders\nSummarize how to balance working with children and their parents in the context of divorce\nList the most recently developed and discovered drugs of abuse\, and their psychiatric sequelae\nDevelop a plan to screen for\, diagnose\, and treat bipolar disorder in their older adult patients\nDevelop and implement a treatment plan for their patients with obsessive-compulsive disorder\nAppreciate the clinical and research links between substance use disorders and eating disorders\nDescribe the steps that health care providers can take to promote wellness within their institutions\n\n\n\n\n\n  \n\n\n\n\nFRIDAY\, OCTOBER 11\n\n\n7:15\nRegistration and Continental Breakfast\n\n\n8:00\nWelcome\nNed Kalin\, MD & Art Walaszek\, MD\n\n\n8:45\nRole of TMS in the Treatment of Major Depressive Disorder\nLinda L. Carpenter\, MD\n\n\n9:45\nQ & A\nModerator: Ned Kalin\, MD\n\n\n10:15\nRefreshment Break\n\n\n10:30\nAn Update on the Treatment of Substance Use Disorders in Adolescents\nJustine W. Welsh\, MD\n\n\n11:30\nQ & A\nModerator: Ned Kalin\, MD\n\n\n12:00\nLunch\n\n\n1:00\nBreakout Sessions & Case Discussions\n1) Strategies for Caring for Patients with Personality Disorders – Erri Hewitt\, PhD\n2) Providing Mental Health Care to Children with Divorced Parents – Jason Horowitz\, PhD\n3) New Drugs the Kids are Using These Days – Jennifer McDonald\, MD\n4) Recognizing and Treating Bipolar Disorder in Older Adults – Eileen Ahearn\, MD\n\n\n2:30\nRefreshment Break\n\n\n2:45\nIn Memoriam – James W. “Jeff” Jefferson\nJohn H. Greist\, MD; Ned Kalin\, MD; & Art Walaszek\, MD\n\n\n3:00\nInaugural James W. Jefferson Lecture\nOptimal Treatment of Obsessive-Compulsive Disorder\nJohn H. Greist\, MD\n\n\n4:00\nQ & A\nModerator: Ned Kalin\, MD\n\n\n4:30\nAdjourn\n\n\n\n\n\n\n\nSATURDAY\, OCTOBER 12\n\n\n7:45\nRegistration and Continental Breakfast\n\n\n8:25\nIntroduction\nNed Kalin\, MD & Art Walaszek\, MD\n\n\n8:30\nMy Career in Translational Addiction Research: From Opioids\, to Cocaine\, to Food\nMark S. Gold\, MD\n\n\n9:30\nQ & A\nModerator: Art Walaszek\, MD\n\n\n10:00\nRefreshment Break\n\n\n10:15\nThe Long Game: Stories of Our Lives in Medicine\nHelping students\, trainees and physicians create and sustain satisfying careers\nJoan M. Anzia\, MD\n\n\n11:15\nQ & A\nModerator: Art Walaszek\, MD\n\n\n11:45\nAdjourn
URL:https://www.psychiatry.wisc.edu/event/7th-annual-update-and-advances-in-psychiatry-conference/
LOCATION:Monona Terrace\, 1 John Nolen Dr\, Madison\, WI\, 53703\, United States
CATEGORIES:CME
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190920T120000
DTEND;TZID=America/Chicago:20190920T130000
DTSTAMP:20260404T042834
CREATED:20190416T154030Z
LAST-MODIFIED:20190712T160850Z
UID:3624-1568980800-1568984400@www.psychiatry.wisc.edu
SUMMARY:Charles B. Nemeroff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Prediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n\nFRIDAY SEPT 13 | 12:00pm\nWisPIC Commons Room 1616\n6001 Research Park Blvd \nCharles B. Nemeroff\, MD\, PhD\nChair and Professor of Psychiatry\nDirector\, Institute for Early Childhood Adversity Research\nUniversity of Texas at Austin – Dell Medical School \nLearning Objectives \n\nTo understand the principles of personalized medicine as applied to mood and anxiety disorders.\nTo understand the role of Genome Wide Association Studies (GWAS)\, candidate gene approaches\, transcriptomics\, epigenetics\, and proteomics in predicting disease treatment response in mood and anxiety disorders.\nTo understand the potential for functional brain imaging for predicting treatment response in mood and anxiety disorders.\nTo understand the role of gene-environment interactions\, particularly early life trauma\, in predicting treatment response in mood disorders.\n\n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America \n  \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH.
URL:https://www.psychiatry.wisc.edu/event/grand-rounds-greenfield-speaker/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190912T170000
DTEND;TZID=America/Chicago:20190912T190000
DTSTAMP:20260404T042834
CREATED:20190416T153918Z
LAST-MODIFIED:20190904T191128Z
UID:3622-1568307600-1568314800@www.psychiatry.wisc.edu
SUMMARY:Greenfield Memorial Lecture: Progress in Suicide Prevention | Charles B. Nemeroff\, MD\, PhD
DESCRIPTION:Progress in Suicide Prevention\nTHURSDAY\, SEPTEMBER 12\, 2019\n5:30 – 7:00PM\nWisconsin Psychiatric Institute and Clinic\n6001 Research Park Boulevard\, Room 1616\n* Light refreshments will be served * \nCharles B. Nemeroff\, MD\, PhD\nProfessor and Acting Chair\nDepartment of Psychiatry\nAssociate Chair for Research\nDirector\, Institute of Early Life Adversity Research\nDell Medical School\, The University of Texas at Austin \n \nSuicide is the 10th leading cause of death in the United States\, the only one of the top ten that is increasing in number year after year. This year there will likely be 50\,000 suicides in the United States (130 per day) and in addition approximately 20\,000 of the 70\,000 opiate overdose deaths each year are classified as suicides. It is the second leading cause of death in the 15-34 year age group. In spite of many public health and education efforts in the past decade\, suicide rates have continued to climb. Research on risk factors for suicide have been informative.  Men are at significantly greater risk for suicide than women. In addition other risk factors that have been clearly documented are a past diagnosis of depression or related psychiatric disorders\,  history of childhood maltreatment including bullying\, family history of suicide (underlying the genetic component of risk)\, alcohol and substance abuse\, as well as more recent life stressors such as loss of job\, a recent serious medical diagnosis\, imminent divorce and recent trauma. The reduction of available psychiatric inpatient beds is also associated with the year over year increase nationally. There is considerable evidence for an underlying neurobiological basis for suicidality including increased inflammation\, decreased activity of serotonergic circuits in the brain and increase activity of the major mammalian stress system\, the pituitary-adrenal axis. Certain medications including lithium and clozapine are known to reduce suicide as are  certain forms of cognitive-behavioral therapy (CBT). Finally providing obstacles to means of suicide has been shown to be effective in reducing suicide rates. \n  \n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America (ADAA). \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH. \n\nAdditional Talk: \nFriday\, Sept 13 – 12:00pm | WisPIC Commons Room\nPsychiatry Grand Rounds \nPrediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n \n\n  \nReading List: \n1. The Holy Grail of Psychiatry (2015) 81-89\n2. Understanding Depression – Contemporary Issues (2017) 21\, 245-261\n3. Psychosomatic Medicine (2014) 76\, 445-451
URL:https://www.psychiatry.wisc.edu/event/greenfield-memorial-lecture-2/
LOCATION:Webex
CATEGORIES:CME
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190823T120000
DTEND;TZID=America/Chicago:20190823T131500
DTSTAMP:20260404T042834
CREATED:20190215T214254Z
LAST-MODIFIED:20190220T215220Z
UID:3515-1566561600-1566566100@www.psychiatry.wisc.edu
SUMMARY:Heather Abercrombie\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Neurocognitive Sensitivity to Cortisol in Depression\n  \nHeather C. Abercrombie\, Ph.D.\nAssociate Professor (CHS)\nUniversity of Wisconsin-Madison\nSchool of Medicine and Public Health\nDepartment of Psychiatry \n\nMany individuals with depression show “glucocorticoid resistance\,” which reflects systemic and cellular insensitivity to the stress-related hormone cortisol.  However\, the neural and psychological relevance of glucocorticoid resistance is unknown. This is a huge gap in our knowledge\, because basic research shows that cortisol has potent yet variable effects on psychological function. Our research addresses this knowledge gap\, and we have shown that glucocorticoid resistance is related to negatively biased emotional memory and related neural circuitry. Importantly\, we have also shown that cortisol augmentation ameliorates negative memory bias in depression\, particularly in glucocorticoid resistant individuals. Taken together\, these findings suggest that glucocorticoid resistance is related to core psychological features of depression\, and that boosting cortisol signal may be psychologically beneficial in glucocorticoid resistant individuals with depression. \n  \nLearning objectives: \n\nDebunk popular notions of cortisol as unequivocally harmful\nUnderstand the relation between cortisol and psychological functions relevant to depression\nUnderstand that cortisol augmentation may be beneficial in depression\n\n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/heather-abercrombie-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190821T120000
DTEND;TZID=America/Chicago:20190821T130000
DTSTAMP:20260404T042834
CREATED:20181004T180657Z
LAST-MODIFIED:20181004T180657Z
UID:3312-1566388800-1566392400@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Eileen P. Ahearn\, MD\, PhD - The Psychopharmacologic Treatment of PTSD
DESCRIPTION:The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \n  \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n8/21/19 – Eileen P. Ahearn\, MD\, PhD – The Psychopharmacologic Treatment of PTSD \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-eileen-p-ahearn-md-phd-the-psychopharmacologic-treatment-of-ptsd/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190628T120000
DTEND;TZID=America/Chicago:20190628T131500
DTSTAMP:20260404T042834
CREATED:20190215T213540Z
LAST-MODIFIED:20190219T155141Z
UID:3511-1561723200-1561727700@www.psychiatry.wisc.edu
SUMMARY:Anna Ratzliff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Implementing Collaborative Care: Translation from Research to Real World\nAnna Ratzliff\, MD\, PhD\nAssociate Professor\nDepression Therapy Research Endowed Professorship\nDirector\, AIMS Center\nDirector\, UW Integrated Care Training Program \n  \nLearning Objectives:\n1)      List common barriers and facilitators to collaborative care implementation.\n2)      Describe five phases to implementation of collaborative care.\n3)      Name common factors influencing the sustainability of collaborative care. \nThis lecture will provide a brief overview of the collaborative care model (CoCM) and review current thinking about implementation of this approach to deliver mental health treatment in primary care settings.  An approach to the five phase of implementation will be discussed including common barriers and facilitators. \n\nDr. Anna Ratzliff is a national expert on collaborative care and specifically\, on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine.  She currently is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington where she has developed expertise in suicide prevention training\, mental health workforce development\, adult learning best practices\, and mentorship. Dr. Ratzliff is the Director of the AIMS Center (Advancing Integrated Mental Health Solutions)\, is the Director of the UW Integrated Care Training Program for residents and fellows\, and leads a national collaborative care training program for the American Psychiatric Association’s Transforming Clinical Practices Initiative grant. For more information on collaborative care please visit the AIMS Center Website (aims.uw.edu)\, the UW Integrated Care Training Program (ictp.uw.edu). \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/anna-ratzliff-md-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/02/Anna-Ratzliff-2018.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190619T120000
DTEND;TZID=America/Chicago:20190619T130000
DTSTAMP:20260404T042834
CREATED:20190215T231216Z
LAST-MODIFIED:20190215T231216Z
UID:3542-1560945600-1560949200@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Steve Garlow\, MD [Topic: Transcranial Magnetic Stimulation]
DESCRIPTION:6/19/19\nSteve Garlow\, MD \nTopic: TMS – Transcranial Magnetic Stimulation\nTitle: TBD \n\nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715
URL:https://www.psychiatry.wisc.edu/event/educational-conference-steve-garlow-md-topic-transcranial-magnetic-stimulation/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190419T120000
DTEND;TZID=America/Chicago:20190419T131500
DTSTAMP:20260404T042834
CREATED:20181120T184303Z
LAST-MODIFIED:20190228T210031Z
UID:3397-1555675200-1555679700@www.psychiatry.wisc.edu
SUMMARY:Boris Birmaher\, MD | UW Psychiatry Grand Rounds
DESCRIPTION:*** Part of the Briskey Family Bipolar Lecture Series*** \nPredicting the Development of Bipolar Disorder and Mood Recurrences –\nToward Personalized Psychiatry\nBoris Birmaher\, MD\nEndowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry\nDirector\, Child and Adolescent Bipolar Spectrum Services\nCo-Director\, Psychiatry Research Pathway Program\nUniversity of Pittsburgh \nLearning objectives: \n\nTo describe the prodromal symptoms of bipolar disorder\nTo describe the course and outcome of bipolar disorder in youth and the factors associated with increases risk for recurrences\nTo describe the use of “risk calculators” to predict “personalized” risk to develop bipolar disorder as well as the risk of recurrences.\n\n\nDr. Birmaher is the Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry at the University of Pittsburgh\, School of Medicine and serves as the Co-Director of the Psychiatry Research Pathway program and the Director of the Child and Adolescent Bipolar Spectrum Services.  He received his medical degree from Valle University in Cali\, Colombia; completed training in general psychiatry at the Hebrew University in Jerusalem\, Israel\, and child psychiatry at Columbia University\, New York. \nDr Birmaher is a leader in the study and treatment of pediatric mood and anxiety disorders. In addition\, his research has concentrated in describing the predictors\, risk factors\, course and treatment of childhood-onset bipolar disorder.  Throughout his career\, he has served as the Principal\, Co-Principal or co-investigator for over 25 federally-sponsored research grants and projects.  He has authored or co-authored more than 430 publications\, numerous book chapters as well as his own book\, New Hope for Children and Teens with Bipolar Disorder.  Dr. Birmaher has been the recipient of numerous awards over the years including the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2013 and the Ittleson Award for Research in Child and Adolescent Psychiatry in 2014.  In 2018\, he received the Gerald L Klerman Senior Investigator Award and the Lifelong Fellow Award from the American Psychiatric Association. For four years and until 10/2018 he was the Program Chair of the American Academy of Child and Adolescent Psychiatry and recently was named Counselor-At-Large of the same association. Through his research\, clinical and mentoring activities\, Dr. Birmaher has increased our understanding of the risk factors for mood and anxiety disorders\, developed and implemented innovative treatments to improve the lives of patients and their families\, and trained the next generation of educators\, clinicians and researchers. \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour. \n 
URL:https://www.psychiatry.wisc.edu/event/boris-birmaher-md-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Educational Conference (Park Street),Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/11/Boris2017-1.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190417T120000
DTEND;TZID=America/Chicago:20190417T120000
DTSTAMP:20260404T042834
CREATED:20181004T180524Z
LAST-MODIFIED:20181004T180524Z
UID:3310-1555502400-1555502400@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Dean Krahn\, MD - Pharmacologic Management of Alcohol Use Disorders
DESCRIPTION:The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \n  \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n4/17/19 – Dean Krahn\, MD – Pharmacologic Management of Alcohol Use Disorders \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-dean-krahn-md-pharmacologic-management-of-alcohol-use-disorders/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190409T170000
DTEND;TZID=America/Chicago:20190409T180000
DTSTAMP:20260404T042834
CREATED:20190402T213629Z
LAST-MODIFIED:20190405T230318Z
UID:3605-1554829200-1554832800@www.psychiatry.wisc.edu
SUMMARY:Depression in Women: the Brain in Context (Public Talk) - David Rubinow\, MD)
DESCRIPTION:*** This talk is free and open to the public! Please share with friends\, family\, and colleagues who may be interested in attending *** \nTo celebrate the 25th annual Wisconsin Symposium on Emotion\, The University of Wisconsin Department of Psychiatry\, along with the HealthEmotions Research Institute and Center for Healthy Minds are pleased to announce a free public talk by distinguished scientist and clinician\, David Rubinow\, MD on Tuesday\, April 9th at 5:00pm in the HSLC auditorium. \n\nOne could argue that the most important question we can ask about brain and behavior is the following: why is it that different people respond differently to the same stimulus? As much as we have learned about neuroscience over the past twenty-five years\, largely consequent to some of the amazing tools that have been developed\, it is overwhelmingly apparent that the brain\, like other organs\, responds very differently to a given signal as a product of context. This context includes past exposure\, sex\, current environment\, genetic inheritance\, and hormonal state. The role of context in the regulation of brain and generation of different behavioral responses is wonderfully illustrated by examining the role of reproductive steroid hormones – estrogen and progesterone – in depression that occurs in women during periods of reproductive change: the menstrual cycle\, peripartum\, and perimenopausal. In this presentation\, I will describe some of the technologies that allow us to peer into the brain and will illustrate how the biology of sex hormones enables us to understand how context shapes the tremendous variability in health and behavior. \n\nDr. David Rubinow is the Assad Meymandi Professor and Chair of the Department of Psychiatry at the University of North Carolina – Chapel Hill\, School of Medicine. Prior to joining UNC\, he was the Clinical Director of the National Institute of Mental Health (NIMH) and Chief of the Behavioral Endocrinology Branch.  His research interests focus on neurobehavioral effects of gonadal steroids and how genetic variation contributes to differential behavioral response to changes in steroid signaling. Research methods used include administration of hormone super agonists and receptor blockers to manipulate the menstrual cycle and identify the central effects of gonadal steroids in isolation. These studies have demonstrated that\, unlike mood disorders accompanying endocrinopathies\, reproductive endocrine-related mood disorders represent abnormal responses to normal hormonal signals. Current NIH funded studies include investigations of continuous oral contraceptive administration in menstrual cycle-related mood disorders\, estradiol effects on cardiovascular risk and mood dysregulation during the perimenopause\, and biomarkers of postpartum depression. Additionally\, the UNC Women’s Mood Disorders Program\, which he directs\, has the first and only NIH training fellowship in Women’s Mood Disorders. On the basis of his research\, he was inducted into the Institute of Medicine of the National Academies in 2012. Dr. Rubinow is also the Director of the UNC Center for Innovation and Health Care System Transformation\, which promotes the development of patient-centered innovations designed to address the current challenges facing our nation’s health care delivery system. \n 
URL:https://www.psychiatry.wisc.edu/event/depression-in-women-the-brain-in-context-public-talk-david-rubinow-md/
LOCATION:Health Sciences Learning Center – Auditorium (HSLC 1306)\, 750 Highland Avenue\, Madison\, WI\, 53705\, United States
CATEGORIES:Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190308T120000
DTEND;TZID=America/Chicago:20190308T131500
DTSTAMP:20260404T042834
CREATED:20190215T212132Z
LAST-MODIFIED:20190220T215057Z
UID:3501-1552046400-1552050900@www.psychiatry.wisc.edu
SUMMARY:Conor Liston\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Neuroimaging Biomarkers for Diagnosing Neurophysiological Subtypes of Depression and Predicting Treatment Response\n  \nConor Liston\, MD\, PhD\nAssistant Professor of Neuroscience\nBrain and Mind Research Institute\nand Department of Psychiatry\nWeill Cornell Medicine \n\nConor Liston\, MD\, PhD is an Associate Professor of Neuroscience and Psychiatry in the Feil Family Brain and Mind Research Institute and the Department of Psychiatry at Weill Cornell Medicine. The long-term goals of his research program are to define mechanisms by which prefrontal cortical brain circuits support learning\, memory\, and motivation\, and to understand how these functions are disrupted in depression\, addictions\, and other stress-related psychiatric disorders. To this end\, experiments in his lab integrate optogenetic tools and genetically encoded calcium indicators with two-photon imaging and functional MRI\, and his team is actively developing new methods for quantifying prefrontal cortical microcircuit dynamics in genetically defined neuronal subtypes. They are also developing novel neuroimaging tools for informing psychiatric diagnosis in human populations and predicting treatment response to transcranial magnetic stimulation (TMS) and other neurostimulatory antidepressant interventions. \nDr. Liston graduated summa cum laude from Harvard College in 1998\, and received his PhD and MD from The Rockefeller University and Weill Cornell Medicine in 2007 and 2008\, respectively\, where he was supported by a Paul and Daisy Soros Fellowship for New Americans. He subsequently completed his residency in psychiatry at New York–Presbyterian Hospital and postdoctoral training at Stanford University. He returned to Weill Cornell as an Assistant Professor in 2014. His research has been recognized with awards from the Klingenstein-Simons Foundation Fund\, the Rita Allen Foundation\, the Dana Foundation\, the Doris Duke Charitable Foundation\, and the One Mind Institute. Dr. Liston is also a clinically active psychiatrist specializing in the management of treatment-resistant mood disorders. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/conor-liston-md-phd-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/02/Liston.jpeg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190220T120000
DTEND;TZID=America/Chicago:20190220T130000
DTSTAMP:20260404T042834
CREATED:20181004T180321Z
LAST-MODIFIED:20190220T215024Z
UID:3308-1550664000-1550667600@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Ronni Hayon\, MD - The "T" in LGBTQ: Providing Compassionate and Appropriate Care to TNG Patients
DESCRIPTION:2/20/19\nRonni Hayon\, MD  \nThe “T” in LGBTQ: Providing Compassionate and Appropriate Care to TNG Patients \n\nLearning Objectives:\n\n\n\n\nExploration of transphobia and privilege\nDiscuss key topics in medical and behavioral health as they relate to the care  of TNG people\nDevelop concrete skills for providing affirming care to TNG people\n\n\n\nRonni Hayon\, MD joined the Department of Family Medicine as an Assistant Professor in October 2012.  She received her medical degree from Drexel University College of Medicine in Philadelphia and she completed her Family Medicine residency at the UW-Madison Family Medicine Residency Program. Following residency\, Dr. Hayon completed a one-year Academic Fellowship with the Department of Family Medicine.  Dr. Hayon has lectured extensively regionally and nationally about LGBTQ health issues\, with a particular focus on transgender wellness. \n\nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n\nAccreditation Statement: \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-ronni-hayon-md-care-of-the-transgender-patient/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20181219T120000
DTEND;TZID=America/Chicago:20181219T130000
DTSTAMP:20260404T042834
CREATED:20180626T192835Z
LAST-MODIFIED:20180822T125808Z
UID:2859-1545220800-1545224400@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Dr. Michelle Poliak-Tunis\, Department of Rehabilitative Medicine - Low Dose Naltrexone
DESCRIPTION:The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \n  \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n12/19/18 – Dr. Michelle Poliak-Tunis\, Department of Rehabilitative Medicine – Low Dose Naltrexone \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-dr-michelle-poliak-tunis-department-of-rehabilitative-medicine-low-dose-naltrexone/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20181130T120000
DTEND;TZID=America/Chicago:20181130T131500
DTSTAMP:20260404T042834
CREATED:20180427T142054Z
LAST-MODIFIED:20180626T193726Z
UID:1311-1543579200-1543583700@www.psychiatry.wisc.edu
SUMMARY:Melissa DelBello\, MD\, MS | UW Psychiatry Grand Rounds
DESCRIPTION:  \nNeuropharmacology of Bipolar Disorder in Youth \nMelissa Delbello\, MD\, MS\, has served as professor and chair of the Department of Psychiatry and Behavioral Neuroscience since 2014. She joined the University of Cincinnati College of Medicine faculty in 2000 as an assistant professor of psychiatry and pediatrics. Dr. DelBello has served in several leadership roles in the Department of Psychiatry and Behavioral Neuroscience\, including vice chair of clinical research since 2007 and co-director of the Division of Bipolar Disorders Research since 2004. She has also been co-director of the Mood Disorders Center at the UC Gardner Neuroscience Institute. A nationally recognized expert on child and adolescent mood disorders\, Dr. DelBello has lectured and published extensively on bipolar disorder and served as principal or co-investigator of several NIH grants. She has been a member of the Neural Basis of Psychopathology\, Addictions and Sleep Disorders Study Section of the Center for Scientific Review at the National Institutes of Health since 2009\, most recently serving as chairperson for a term running from July 2012 through June 2014. Since 2012 she has chaired the Research Committee of the American Academy of Child and Adolescent Psychiatry. At UC Medical Center\, she has served as medical director of the Resident Mood Medication Clinic since its launch in September 2013. She is co-director of the Mood Disorders Program at Cincinnati Children’s Hospital Medical Center. Dr. DelBello is a fellow of the American Academy of Child and Adolescent Psychiatry and also holds membership in the American Psychiatric Association\, International Society for Bipolar Disorders and American College of Neuropsychopharmacology. A native of New York City\, Dr. DelBello received her bachelor of science degree with honors from Cornell University and her medical degree with honors from the University of Rochester School of Medicine. She completed residencies in psychiatry at Cornell Medical Center (1995-96) and the UC College of Medicine (1996-98). In addition\, she holds a master’s in epidemiology and biostatistics from UC. \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/melissa-delbello-md-ms/
LOCATION:Webex
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/05/melissa-delbello_400.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20181119T160000
DTEND;TZID=America/Chicago:20181119T171500
DTSTAMP:20260404T042834
CREATED:20181019T193528Z
LAST-MODIFIED:20181024T191205Z
UID:3325-1542643200-1542647700@www.psychiatry.wisc.edu
SUMMARY:Seminar: Noninvasive Brain Stimulation and Inhibitory Learning: Implications for the Behavioral Treatment of Anxiety and Related Disorders - Thomas Adams\, PhD
DESCRIPTION:Noninvasive Brain Stimulation and Inhibitory Learning: \nImplications for the Behavioral Treatment of Anxiety and Related Disorders\n Thomas G. Adams Jr.\, Ph.D.  \nClinical Psychologist\nAssistant Professor\nDepartment of Psychiatry\nYale University School of Medicine \n\nThomas Adams\, PhD\, received his bachelor’s degree from the University of Wisconsin-Milwaukee in 2006 and his Ph.D. in clinical psychology from the University of Arkansas in 2014 following the completion of a pre-doctoral internship within the traumatic stress track at the Charleston Consortium at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center. He joined the research faculty in Yale’s Department of Psychiatry following the completion of a NIMH-funded postdoctoral fellowship. He works primarily as a researcher at the Yale OCD Research Clinic and within the Clinical Neuroscience Division of the VA National Center for PTSD\, and additionally provides instruction\, clinical supervision\, research mentorship\, and private clinical services. \n\n  \n 
URL:https://www.psychiatry.wisc.edu/event/seminar-noninvasive-brain-stimulation-and-inhibitory-learning-implications-for-the-behavioral-treatment-of-anxiety-and-related-disorders-thomas-adams-phd/
LOCATION:WisPIC (HERI) Louis A. Holland Family Boardroom\, 6001 Research Park Blvd\, Madison\, WI\, 53719\, United States
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20181017T120000
DTEND;TZID=America/Chicago:20181017T130000
DTSTAMP:20260404T042834
CREATED:20180822T125711Z
LAST-MODIFIED:20180822T125711Z
UID:3072-1539777600-1539781200@www.psychiatry.wisc.edu
SUMMARY:Educational Conference:  Ketty Thertus MD - Updates in the Treatment of  Pain in Patients with Psychiatric Disorders
DESCRIPTION:The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \n  \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n10/17/18 – Ketty Thertus MD – Updates in the Treatment of Pain in Patients with Psychiatric Disorders \n\n\nACCREDITATION STATEMENT\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCREDIT DESIGNATION STATEMENT:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-ketty-thertus-md-updates-in-the-treatment-of-pain-in-patients-with-psychiatric-disorders/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181012
DTEND;VALUE=DATE:20181014
DTSTAMP:20260404T042834
CREATED:20180616T215015Z
LAST-MODIFIED:20180823T151716Z
UID:2435-1539302400-1539475199@www.psychiatry.wisc.edu
SUMMARY:6th Annual Update & Advances in Psychiatry Conference
DESCRIPTION:For complete information\, visit event webpage. \nBrochure: 2018 Update & Advances in Psychiatry \n\nPRESENTERS\n\nVISITING FACULTY\nJosepha A. Cheong\, MD\nProfessor\, Departments of Psychiatry and Neurology\, University of Florida College of Medicine; Chief\, Psychiatry Consult-Liaison Service\, Malcom Randall VA Medical Center; Gainesville\, FL \nCharles DeBattista\, DMH\, MD\nProfessor of Psychiatry and Behavioral Sciences; Stanford University School of Medicine; Stanford\, CA \nEllen Leibenluft\, MD\nSenior Investigator\, NIMH Intramural Research Program; Bethesda\, MD \nFrances R. Levin\, MD\nKennedy-Leavy Professor of Psychiatry at Columbia University Medical Center\, New York\, NY \nStephen R. Marder\, MD\nDaniel X. Freedman Professor of Psychiatry; Vice Chair for Education; Semel Institute for Neuroscience at UCLA; Director\, VA Desert Pacific Mental Illness Research\, Education\, and Clinical Center; Los Angeles\, CA \nUNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH FACULTY\nStuart W. Jones\, MD\nClinical Assistant Professor of Psychiatry and Associate Residency Training Director \nNed H. Kalin\, MD\nHedberg Professor and Chair of Psychiatry \nCharlotte Ladd\, MD\nClinical Associate Professor of Psychiatry \nMichael J. Peterson\, MD\, PhD\nAssociate Professor (CHS); Director of Hospital Psychiatric Services \nKetty Thertus\, MD\nAssistant Professor of Psychiatry; Director\, Adult Consultation Liaison Service \nArt Walaszek\, MD\nProfessor of Psychiatry \n\nREGISTRATION INFORMATION\n\nCONFERENCE FEES\n$365 – Physicians (MD/DO) and PhDs \n$265 – Other (Adjunct Clinical Faculty\, PA\, NP\, RN\, etc.) \n$125 – UW SMPH/UW Health/UW Medical Foundation/VA/Meriter Faculty\, Residents\, and Staff \nThe conference fee includes the cost of tuition\, continental breakfasts\, lunch\, refreshment breaks\, and a nonrefundable processing fee of $50. \n\nREGISTER/ENROLLMENT INFORMATION\nVisit https://ce.icep.wisc.edu/2018-Annual-Update \n• Select the “Register” tab \n• Select login or register \n• If you have a UW-Madison NetID: Select “Login with my UW-Madison NetID” \n• If you do not have a UW-Madison NetID\, please click on Visitor: Select “I already have an account” or “Create an account login and password” \n• Follow any prompts to complete or update your profile information \n• Once you are logged in\, navigate back to:https://ce.icep.wisc.edu/2018-Annual-Update \n• Click the “Register” tab\, select your fee\, complete any additional registration questions\, and click\, “Add to Cart” \n• Select “Checkout” and follow the prompts to pay for the conference \nContact help@icep.wisc.edu if you need assistance.
URL:https://www.psychiatry.wisc.edu/event/6th-annual-update-advances-in-psychiatry-conference/
LOCATION:Monona Terrace Community and Convention Center\, 1 John Nolan Drive\, Madison\, Wisconsin\, 53703
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20181007T120000
DTEND;TZID=America/Chicago:20181007T133000
DTSTAMP:20260404T042834
CREATED:20180925T174035Z
LAST-MODIFIED:20180925T174035Z
UID:3261-1538913600-1538919000@www.psychiatry.wisc.edu
SUMMARY:NAMI Walk
DESCRIPTION:  \n\n\n\nThe UW Department of Psychiatry invites you to take part in the 13th Annual NAMIWalks Dane County\, to be held on Sunday\, October 7th at Olin-Turville Park.  Registration and festivities begin at 10:30am\, and the Walk will start at Noon.  Please come early so you can enjoy the refreshments\, games and entertainment! \nJoin or donate to one of the UW Health Psychiatry Teams: \n\nUW Health – UW Department of Psychiatry\nUW Health – B6/5 Psychiatry \nUW Health – Psychiatry Residents\n\n  \nOr visit the NAMIWalks Dane County webpage to create your own team\, register\, or make a donation! \nBy partnering with organizations like NAMI\, we hope to raise awareness\, reduce stigma\, and improve the lives of millions of individuals and families impacted by mental illness by increasing access to affordable quality mental healthcare services & resources\, advocating for policies that support mental health initiatives\, and increasing funding for scientific research and the development of treatments that reduce suffering and increase well-being.
URL:https://www.psychiatry.wisc.edu/event/nami-walk/
LOCATION:Olin-Turville Park\, 1156 Olin-Turville Ct\, Madison\, WI\, 53715
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/01/48A2740.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180924T170000
DTEND;TZID=America/Chicago:20180924T183000
DTSTAMP:20260404T042834
CREATED:20180530T200920Z
LAST-MODIFIED:20180531T133439Z
UID:1927-1537808400-1537813800@www.psychiatry.wisc.edu
SUMMARY:Ann E. Kelley Travel Award Reception
DESCRIPTION:This small reception honors the legacy of Dr. Ann Kelley and this year’s recipient of the Anne E. Kelley Travel Award. The reception is not open to the public; it is intended for friends and family of Dr. Kelley\, the award recipient\, and other colleagues and researchers affiliated with the UW Department of Psychiatry and/or neuroscience programs.
URL:https://www.psychiatry.wisc.edu/event/ann-e-kelley-travel-award-reception/
LOCATION:WisPIC\, 6001 Research Park Blvd\, Madison\, WI\, 53719
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180913T120000
DTEND;TZID=America/Chicago:20180913T131500
DTSTAMP:20260404T042834
CREATED:20180616T220603Z
LAST-MODIFIED:20180822T142931Z
UID:2448-1536840000-1536844500@www.psychiatry.wisc.edu
SUMMARY:Daniel Pine\, MD | UW Psychiatry Grand Rounds
DESCRIPTION: Using Neuroscience to Inform Clinical Thinking in Pediatric Anxiety \n  \nDr. Daniel Pine is Chief\, Section on Development and Affective Neuroscience\, in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000\, after 10 years of training\, teaching\, and research at Columbia University. Since graduating from medical school at the University of Chicago\, Dr. Pine has been engaged continuously in research on pediatric mental disorders\, as reflected in more than 500 peer-reviewed papers. Currently\, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration\, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force\, and President of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards. \n\n\nACCREDITATION STATEMENT\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCREDIT DESIGNATION STATEMENT:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/daniel-pine-md-uw-psychiatry-grand-rounds/
LOCATION:Webex
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180912T173000
DTEND;TZID=America/Chicago:20180912T190000
DTSTAMP:20260404T042834
CREATED:20180616T215639Z
LAST-MODIFIED:20180626T193422Z
UID:2439-1536773400-1536778800@www.psychiatry.wisc.edu
SUMMARY:Greenfield Memorial Lecture
DESCRIPTION:Greenfield Memorial Lecture\nWednesday\, Sept 12th 5:30-7pm\n* Light refreshments will be served *\nRSVP: sebastian@wisc.edu \n CURRENT TREATMENTS FOR PEDIATRIC MOOD AND ANXIETY DISORDERS\n \n Daniel Pine\, M.D.\nChief\, Emotion and Development Branch (E & D)\nChief\, Section on Development and Affective Neuroscience (SDAN)\nNational Institute of Mental Health \n\nDr. Daniel Pine is Chief\, Section on Development and Affective Neuroscience\, in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000\, after 10 years of training\, teaching\, and research at Columbia University. Since graduating from medical school at the University of Chicago\, Dr. Pine has been engaged continuously in research on pediatric mental disorders\, as reflected in more than 500 peer-reviewed papers. Currently\, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration\, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force\, and President of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards. \n\nABOUT NORMAN GREENFIELD AND THE GREENFIELD LECTURE\nThis annual lecture honors the legacy of Norman S. Greenfield\, former Professor of Psychiatry and Associate Director and co-founder of the Wisconsin Psychiatric Institute. The lecture fosters educational efforts related to understanding neuroplastic mechanisms underlying change with effective treatments\, especially psychotherapy. \nDr. Greenfield played a key role in fostering early scientific investigations into the role of psychophysiological correlates of psychological disorders and the processes involved in personality change\, as exemplified by his books “Psychoanalysis and Current Biological Thought” and “The Handbook of Psychophysiology.” \nAdditionally\, Dr. Greenfield was very dedicated to the supervision of psychiatry residents and preparing them to effectively integrate psychotherapy with pharmacology in their treatment of patients. The early values he brought to the University of Wisconsin Department of Psychiatry\, using rigorous scientific methods to integrate psychology with psychiatry to improve the lives of those suffering from mental illness\, continue today as the Department of Psychiatry’s guiding principles. \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/greenfield-memorial-lecture/
LOCATION:Webex
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/01/smph062410_12-e1518729531897.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180912T120000
DTEND;TZID=America/Chicago:20180912T130000
DTSTAMP:20260404T042834
CREATED:20180822T125510Z
LAST-MODIFIED:20180822T125510Z
UID:3070-1536753600-1536757200@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Kavita Poddar - State of the Heart – Diet and Nutrition Perspective
DESCRIPTION:The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \n  \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n9/12/18 – Kavita Poddar – State of the Heart – Diet and Nutrition Perspective \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-kavita-poddar-state-of-the-heart-diet-and-nutrition-perspective/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180910T150000
DTEND;TZID=America/Chicago:20180910T160000
DTSTAMP:20260404T042834
CREATED:20180822T142050Z
LAST-MODIFIED:20180907T174331Z
UID:3075-1536591600-1536595200@www.psychiatry.wisc.edu
SUMMARY:SEMINAR: Sleep Spindle Deficits in Schizophrenia: Established Findings\, New Data\, and Future Directions
DESCRIPTION:Sleep Spindle Deficits in Schizophrenia:\nEstablished Findings\, New Data\, and Future Directions\n\nDr. Ferrarelli’s primary research interests involve the utilization of neuroimaging and neurophysiological techniques\, including high density (hd)-EEG\, fMRI and Transcranial Magnetic Stimulation (TMS) to better understand the neurobiology of major psychiatric disorders\, and especially schizophrenia (SCZ). Dr. Ferrarelli earned his MD and PhD in psychiatry at the Catholic University of the Sacred Heart in Rome. At the University of Wisconsin-Madison\, and while completing his residency at Western Psychiatric Institute and Clinic at Pittsburgh\, he studied the alterations in neuronal circuits contributing to SCZ and related disorders both during wakefulness and sleep. In wakefulness\, he demonstrated a reduction of TMS-evoked fast oscillations in frontal areas in SCZ patients relative to healthy control (HC). In sleep\, he established marked deficits in sleep spindles\, waxing/waning\, 12-16 Hz oscillations that represent a hallmark of Stage 2 Non-Rapid Eye Movement (N2) Sleep\, in SCZ compared to both HC and other psychiatric patients. Dr. Ferrarelli\, who is currently an Assistant Professor\, an Attending Physician\, as well as the Director of the Sleep and Schizophrenia program at the Department of Psychiatry at Pittsburgh\, will now extend those lines of research to early course SCZ as well as individuals at clinical high risk for psychosis. \n\nNote: This seminar is not open to the public. It is intended for UW faculty and researchers involved in Psychiatric and Neuroscientific investigations related to sleep and schizophrenia. If you would like to attend\, simply check with the organizer: sebastian@wisc.edu
URL:https://www.psychiatry.wisc.edu/event/seminar-sleep-spindle-deficits-in-schizophrenia-established-findings-new-data-and-future-directions/
LOCATION:Webex
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180901
DTEND;VALUE=DATE:20180902
DTSTAMP:20260404T042834
CREATED:20180530T195731Z
LAST-MODIFIED:20180824T172301Z
UID:1925-1535760000-1535846399@www.psychiatry.wisc.edu
SUMMARY:Deadline to Apply for Ann E. Kelley Travel Award
DESCRIPTION:The Ann E. Kelley Fellowship in Behavioral Neuroscience honors the legacy of Dr. Kelley and supports the training of future generations of behavioral neuroscientists that embody her passion for understanding the brain with the ultimate goal of using this knowledge to reduce human suffering. \nThe UW Department of Psychiatry invites University of Wisconsin graduate students presenting a paper or poster relevant to behavioral neuroscience at the Society for Neuroscience’s (SfN) annual meeting in San Diego on November 03-07\, 2018 to apply for the Ann E. Kelley Travel Award. The winner will receive an award of $600 to assist with travel expenses. \nApplications will be accepted from August 1\, 2018 to September 1\, 2018. This is a competitive award; the entries will be judged by a committee of UW Department of Psychiatry faculty members. The winner will be notified by September 15\, 2018 and a reception will be held at WisPIC on Monday\, September 24\, 2018 from 5:00pm – 6:30pm. \nPlease submit your application to sebastian@wisc.edu in the form of one PDF file that contains the following documents in this exact order: \n\nApplication Form \nAbstract\nPersonal statement of research interest (one page limit)\nCurrent CV\nLetter from your mentor that includes a statement of student merit\n\nQuestions can be directed to: sebastian@wisc.edu
URL:https://www.psychiatry.wisc.edu/event/deadline-to-apply-for-ann-e-kelley-travel-award/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180815T120000
DTEND;TZID=America/Chicago:20180815T130000
DTSTAMP:20260404T042834
CREATED:20180626T184352Z
LAST-MODIFIED:20180626T192544Z
UID:2849-1534334400-1534338000@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Melody Cole\, Department of Staff Education - Motivational Interviewing (Part 2)
DESCRIPTION:The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \n  \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n3/7/18 – Melody Cole\, Department of Staff Education – Motivational Interviewing (Part 1) \n8/15/18 – Melody Cole\, Department of Staff Education – Motivational Interviewing (Part 2) \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-melody-cole-department-of-staff-education-motivational-interviewing-part-2/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180803T120000
DTEND;TZID=America/Chicago:20180803T131500
DTSTAMP:20260404T042834
CREATED:20180427T141917Z
LAST-MODIFIED:20180626T193254Z
UID:1309-1533297600-1533302100@www.psychiatry.wisc.edu
SUMMARY:Andrew H. Miller\, MD | UW Psychiatry Grand Rounds
DESCRIPTION:Inflammation and Depression: Mechanisms\, Mediators and Therapeutic Implications \nAndrew Miller\, MD is William P. Timmie Professor of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta\, Georgia. He is also the Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences and Director of the Emory Behavioral Immunology Program. Finally\, Dr. Miller is the co-leader of the Cancer Prevention and Control Research Program Research at the Winship Cancer Institute. Dr. Miller is an internationally recognized leader in the area of brain-immune interactions as they relate to depression in medically healthy as well as medically ill patients including patients with cancer. His work has demonstrated that during immune activation\, inflammatory cytokines can access the brain and interact with the metabolism of dopamine and glutamate\, while altering neurocircuits in the brain relevant to motivation and reward as well as anxiety and alarm. Dr. Miller has also studied the impact of cytokines on neuroendocrine regulation and sleep including the study of the specific signal transduction pathways involved. Additionally\, Dr. Miller and his group conducted the first clinical trial examining the efficacy of a cytokine antagonist for the treatment of depression. He has produced over 200 scholarly publications and edited a book entitled Depressive Disorders and Immunity. Dr. Miller’s research awards include the Curt Richter Award from the International Society of Psychoneuroendocrinology and the Norman Cousins Award from the Psychoneuroimmunology Research Society. Aside from his research endeavors\, Dr. Miller has won numerous teaching and mentoring awards and is a Board Certified Psychiatrist and past examiner for the American Board of Psychiatry and Neurology. \n\n\nAccreditation Statement\nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement:\nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
URL:https://www.psychiatry.wisc.edu/event/andrew-h-miller-md/
LOCATION:Webex
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/05/Miller-Picture.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20180720T110000
DTEND;TZID=America/Chicago:20180720T120000
DTSTAMP:20260404T042834
CREATED:20180628T150859Z
LAST-MODIFIED:20180628T150859Z
UID:2872-1532084400-1532088000@www.psychiatry.wisc.edu
SUMMARY:“Towards Computational Phenotypes in Psychiatry” - Amy L. Cochran\, PhD
DESCRIPTION:“Towards Computational Phenotypes in Psychiatry” \nAmy L. Cochran\, PhD\nResearch Associate\nBiostatistics and Medical Informatics\nUniversity of Wisconsin \n\nFriday July 20th – 11 AM – 12 noon\nWISPIC Commons Room \n\n  \n \nAmy L. Cochran\, Ph.D completed her Ph.D. in Applied Mathematics from Cornell University in 2013 and was a T.H. Hildebrandt Research Assistant Professor in the Mathematics Department at the University of Michigan. She is now a NIMH K01 awardee in Biostatistics and Medical Informatics at the University of Wisconsin. Her research interests lie at the intersection of mathematics and psychiatry. She relies on a broad suite of applied math techniques\, such as modeling\, simulation\, and statistics\, to tackle problems in psychiatry. She is interested in describing (precisely with mathematics) mood changes on an individual patient basis. She hopes that this information can lead to personalized treatment of bipolar disorder which accounts for a patient’s unique illness course. Her most recent project looks to systematically determine basic principles of how mood changes in bipolar I patients\, e.g. whether mood fluctuates rhythmically. Future work aims to use smart-phone technology and mathematics to track mood in bipolar patients more precisely and in real time. Amy is one of three editors of the book Computational Neurology and Psychiatry.
URL:https://www.psychiatry.wisc.edu/event/towards-computational-phenotypes-in-psychiatry-amy-l-cochran-phd/
LOCATION:Webex
ORGANIZER;CN="Zachary Stowe%2C MD":MAILTO:zstowe@wisc.edu
END:VEVENT
END:VCALENDAR